Italia markets close in 49 minutes

AstraZeneca PLC (0A4J.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
78,30-0,20 (-0,25%)
In data: 03:23PM BST. Mercato aperto.

AstraZeneca PLC

1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
United Kingdom
44 20 3749 5000
https://www.astrazeneca.com

Settore/i
Settore
Impiegati a tempo pieno89.900

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Pascal Soriot D.V.M., M.B.A.CEO & Executive Director5,94MN/D1959
Dr. Aradhana Sarin M.D.CFO & Executive Director3,27MN/D1974
Ms. Pam P. ChengEVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. BoardN/DN/D1970
Mr. Andrew P. BarnettHead of Investor RelationsN/DN/DN/D
Mr. Jeffrey PottCHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory BoardN/DN/DN/D
Gonzalo VinaHead of Global Media RelationsN/DN/DN/D
Dr. Ruud Dobber Ph.D.Executive Vice-President of BioPharmaceuticals Business UnitN/DN/DN/D
Dr. Susan Mary Galbraith M.D., Ph.D.Executive Vice President of Oncology Research & DevelopmentN/DN/D1966
Mr. Leon WangExecutive VP of International & China PresidentN/DN/DN/D
Ms. Iskra ReicExecutive Vice-President of Vaccines & Immune TherapiesN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and BenevolentAI for drug discovery for systemic lupus erythematosus. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Governance aziendale

L'ISS Governance QualityScore di AstraZeneca PLC al 1 luglio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 3; diritti degli azionisti: 10; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.